Hungarian authorities review Sinopharm vaccine production in Beijing

Experts of the National Institute of Pharmacy and Nutrition (OGYEI) have reviewed production of the Sinopharm Covid-19 vaccine in Beijing, department head Ferenc Lukacs told MTI by phone on Saturday.

Lukács said the experts had conducted a Good Manufacturing Practice (GMP) inspection of the facility where the vaccine is made, reviewing the entire production line and obtaining the full documentation on production processes.

“Everything we wanted to see, we got to see,” he added.

Lukács said the vaccine can be stored at a temperature of between 2 and 8 degree Celsius, making safe delivery “easy to ensure”.

Gergely Gulyás, who heads the Prime Minister’s Office, said at a press briefing on Thursday that

Hungary had “practically reached an agreement” on a delivery of the Sinopharm vaccine.

He added that the first shipment could be as large as one million doses, pending approval by Hungarian medicines authorities.

As we wrote before, a Hungarian opposition party is launching a petition against allowing inoculation in Hungary with a Chinese Covid-19 vaccine that has not been approved by the European Medicines Agency (EMA), details HERE.